*These authors contributed equally to the preparation of this manuscript. Cell-based technologies for printing protein microarrays are faced with poor protein expression, protein insolubility, ...
BOSTON--(BUSINESS WIRE)--Sengenics Corporation LLC, a leader in immune response profiling to support scientific discovery and diagnostic development, today announced the launch of i-Ome Discovery, a ...
The rising incidence of chronic conditions like cancer, diabetes, and cardiovascular diseases is expected to fuel the protein chip market, as research and development efforts intensify to better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback